1. Home
  2. GYRE vs UTZ Comparison

GYRE vs UTZ Comparison

Compare GYRE & UTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GYRE
  • UTZ
  • Stock Information
  • Founded
  • GYRE 2002
  • UTZ 2018
  • Country
  • GYRE United States
  • UTZ United States
  • Employees
  • GYRE N/A
  • UTZ N/A
  • Industry
  • GYRE Biotechnology: Pharmaceutical Preparations
  • UTZ Packaged Foods
  • Sector
  • GYRE Health Care
  • UTZ Consumer Staples
  • Exchange
  • GYRE Nasdaq
  • UTZ Nasdaq
  • Market Cap
  • GYRE 1.1B
  • UTZ 1.3B
  • IPO Year
  • GYRE N/A
  • UTZ N/A
  • Fundamental
  • Price
  • GYRE $10.95
  • UTZ $14.25
  • Analyst Decision
  • GYRE
  • UTZ Buy
  • Analyst Count
  • GYRE 0
  • UTZ 10
  • Target Price
  • GYRE N/A
  • UTZ $20.10
  • AVG Volume (30 Days)
  • GYRE 129.2K
  • UTZ 956.0K
  • Earning Date
  • GYRE 11-13-2024
  • UTZ 02-27-2025
  • Dividend Yield
  • GYRE N/A
  • UTZ 0.84%
  • EPS Growth
  • GYRE N/A
  • UTZ N/A
  • EPS
  • GYRE N/A
  • UTZ N/A
  • Revenue
  • GYRE $105,033,000.00
  • UTZ $1,420,335,000.00
  • Revenue This Year
  • GYRE $25.32
  • UTZ N/A
  • Revenue Next Year
  • GYRE $12.95
  • UTZ $3.13
  • P/E Ratio
  • GYRE N/A
  • UTZ N/A
  • Revenue Growth
  • GYRE N/A
  • UTZ N/A
  • 52 Week Low
  • GYRE $8.26
  • UTZ $13.36
  • 52 Week High
  • GYRE $26.37
  • UTZ $20.04
  • Technical
  • Relative Strength Index (RSI)
  • GYRE 48.93
  • UTZ 37.96
  • Support Level
  • GYRE $9.51
  • UTZ $13.36
  • Resistance Level
  • GYRE $11.11
  • UTZ $14.08
  • Average True Range (ATR)
  • GYRE 0.85
  • UTZ 0.55
  • MACD
  • GYRE 0.04
  • UTZ -0.04
  • Stochastic Oscillator
  • GYRE 29.33
  • UTZ 35.69

About GYRE Gyre Therapeutics Inc.

Gyre Therapeutics Inc is a biopharmaceutical company headquartered in San Diego, CA, that is primarily focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis), formerly known as Nonalcoholic Steatohepatitis (NASH)) in the United States. In the United States, Hydronidone is currently being evaluated for the treatment of liver fibrosis across a broad spectrum of chronic liver diseases under an active Investigational New Drug (IND) application. Gyre is also advancing a diverse pipeline in China through a controlling interest in the Beijing Continent, including pirfenidone, F573, F528, and F230.

About UTZ Utz Brands Inc

Utz Brands Inc is a snack food manufacturing company. It manufactures a diverse portfolio of salty snacks under popular brands including Utz, Zapp's, Golden Flake, Boulder Canyon, Hawaiian, TORTIYAHS!, among others. The company's products include potato chips, tortilla chips, pretzels, cheese snacks, pork skins, veggie snacks, pub/party mixes, and other snacks.. Its products are distributed nationally and internationally through grocery, mass merchant, club, convenience, drug, and other channels. It operates in the given segment: the manufacturing, distribution, marketing and sale of snack food products.

Share on Social Networks: